Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio (2017)
Crinetics Pharmaceuticals (CRNX) recorded quarterly Interest Coverage Ratio of 2501.0 in Q4 2017, down 110.7% quarter-over-quarter from 1187.0 in Q3 2017.
Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio (2017) Analysis & Trends
Crinetics Pharmaceuticals' Interest Coverage Ratio history runs 1 years deep, the most recent figure standing at 2501.0 for Q4 2017.
- In Q4 2017, Interest Coverage Ratio changed N/A year-over-year to 2501.0; the TTM figure through Sep 2018 stood at 21780.0 (changed N/A YoY), while the FY2017 annual figure was 1140.88, down 107.64% from the prior year.
- Interest Coverage Ratio was 2501.0 for Q4 2017 at Crinetics Pharmaceuticals, down from 1187.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 547.67 in Q2 2017 to a low of 2501.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Crinetics Pharmaceuticals | 3.75 Bn | 3.75 Bn | 10.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -2,501.00 |
| Sep 30, 2017 | -1,187.00 |
| Jun 30, 2017 | -547.67 |